Molecular markers of myeloma cell sensitivity vs. resistance to heterobifunctional degraders of oncoproteins: therapeutic implications

Ryosuke Shirasaki, Ricardo de Matos Simoes, Sara Gandolfi, Geoffrey Matthews, Dennis Buckley, Joseline Raja, Quinlan Sievers, Johanna Bruggenthies, Olga Dashevsky, Haley Poarch, Huihui Tang, Megan Bariteau, Michal Sheffer, Yiguo Hu, Sondra Downey-Kopyscinski, Paul Hengeveld, Brian J. Glassner, Eugen Dhimolea, Christopher Ott, Tinghu ZhangNicholas Kwiatkowski, Jacob Laubach, Robert Schlossman, Aedin Culhane, Paul G. Richardson, Richard Groen, Eric Fischer, Francisca Vazquez, Aviad Tsherniak, William Hahn, Joan Levy, Daniel Auclair, Jonathan Licht, Jonathan Keats, Lawrence Boise, Benjamin Ebert, James Bradner, Nathanael Gray, Constantine Mitsiades

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)E134-E134
JournalClinical Lymphoma Myeloma and Leukemia
Volume19
Issue number10
Publication statusPublished - Oct 2019

Cite this